Veterinary Medicines

Depomycine, suspensie voor injectie

Authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
Depomycine, suspensie voor injectie
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
  • Pig
  • Pig (piglet)
  • Cattle (calf)
  • Sheep
  • Sheep (lamb)
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        56
        day
    • Pig
      • Meat and offal
        49
        day
    • Pig (piglet)
      • Meat and offal
        49
        day
    • Cattle (calf)
      • Meat and offal
        56
        day
    • Sheep
      • Meat and offal
        56
        day
    • Sheep (lamb)
      • Meat and offal
        56
        day
    • Dog
    • Cat
  • Subcutaneous use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        56
        day
    • Pig
      • Meat and offal
        49
        day
    • Pig (piglet)
      • Meat and offal
        49
        day
    • Cattle (calf)
      • Meat and offal
        56
        day
    • Sheep
      • Meat and offal
        56
        day
    • Sheep (lamb)
      • Meat and offal
        56
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 4264
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."